ATOSSA THERAPEUTICS INC. - COMMON STOCK
1.2200
22-11月-24 16:44:58
15 分の遅延
株式
+0.0300
+2.52%
本日の幅
1.1700 - 1.2300
ISIN
N/A
ソース
NASDAQ
-
06 3 2024 08:30:00 提供 Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces First Patient Dosing of (Z)-Endoxifen in the Ongoing RECAST DCIS Study
22 2 2024 08:30:00 提供 Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Full Enrollment of (Z)-Endoxifen Arm of I-SPY 2 Clinical Trial
07 2 2024 08:30:00 提供 Nasdaq GlobeNewswire
-
Atossa Therapeutics Issues Letter to Shareholders
09 1 2024 08:30:00 提供 Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces the Appointment of Arezoo Mirad, M.D., as Senior Medical Director
04 12 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Full Enrollment of Phase 2 Karisma-Endoxifen Clinical Trial
20 11 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
13 11 2023 09:00:00 提供 Nasdaq GlobeNewswire
-
Atossa Therapeutics Appoints Financial Executive Jonathan Finn to its Board of Directors
09 11 2023 09:00:00 提供 Nasdaq GlobeNewswire
-
Atossa to Present at Cantor Fitzgerald Global Healthcare Conference 2023
18 9 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
14 8 2023 08:30:03 提供 Nasdaq GlobeNewswire
-
08 8 2023 09:00:00 提供 Nasdaq GlobeNewswire
-
20 7 2023 09:15:00 提供 Nasdaq GlobeNewswire
-
Atossa Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements
13 7 2023 16:15:00 提供 Nasdaq GlobeNewswire
-
Atossa Therapeutics Provides Enrollment Update for Ongoing Phase 2 Karisma-Endoxifen Clinical Trial
10 7 2023 09:15:00 提供 Nasdaq GlobeNewswire
-
06 7 2023 09:15:00 提供 Nasdaq GlobeNewswire
-
28 6 2023 09:15:00 提供 Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces $10M Stock Repurchase Program
27 6 2023 09:15:00 提供 Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Sponsorship of Are You Dense MusicFest 2023
22 6 2023 16:15:00 提供 Nasdaq GlobeNewswire
-
Atossa Therapeutics Granted Additional Patent Protection for Endoxifen
21 6 2023 10:13:54 提供 Nasdaq GlobeNewswire
-
Atossa to Participate in Fireside Chat at Healthcare Virtual Conference Presented by Maxim Group LLC
14 6 2023 09:15:00 提供 Nasdaq GlobeNewswire